| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |